Analysis

October’s top stories: Eurocine Vaccines initiated influenza vaccine study, IVF usage led to conceiving male child

October’s top stories: Eurocine Vaccines initiated influenza vaccine study, IVF usage led to conceiving male child

September's top stories: Oncternal begins TK216 trial, Medical cannabis trials begin in Canada

September's top stories: Oncternal begins TK216 trial, Medical cannabis trials begin in Canada

August's top stories: Gradalis' Phase I breast cancer trial, Biothera and Merck conducted combination cancer immunotherapy trials

August's top stories: Gradalis' Phase I breast cancer trial, Biothera and Merck conducted combination cancer immunotherapy trials

Pharma Technology Focus – Issue 50

Pharma Technology Focus – Issue 50

July's top stories: GBT's Phase II1 trial GBT440, Merck's Phase III trial ONCEMRK of Isentress

July's top stories: GBT's Phase II1 trial GBT440, Merck's Phase III trial ONCEMRK of Isentress

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

June's top stories: Bayer reported positive results of RESORCE trial, TapImmune initiated Phase II trial of TPIV 200

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial

May's top stories: ProMedica began human stem cell trial, Cerulean dosed in Phase l/ll combination trial

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

April's top stories: SynbiCITE's synthetic biology foundry, Omeros's phase II clinical trial of OMS721

March's top stories: Tracon's Phase IbTRC105 clinical trial, ADC begins ADCT-402 trial

March's top stories: Tracon's Phase IbTRC105 clinical trial, ADC begins ADCT-402 trial

Pharma Technology Focus – Issue 45

Pharma Technology Focus – Issue 45

February's top stories: 60% of trial results not shared, Dilaforette-AGU team-up

February's top stories: 60% of trial results not shared, Dilaforette-AGU team-up

Pharma Technology Focus - Issue 44

Pharma Technology Focus - Issue 44

January's top stories: Profectus Ebola trial, AstraZeneca-Incyte lung cancer drug

January's top stories: Profectus Ebola trial, AstraZeneca-Incyte lung cancer drug

Pharma Technology Focus – Issue 43

Pharma Technology Focus – Issue 43

2015: The year's biggest Drug Development Technology stories

2015: The year's biggest Drug Development Technology stories

November's top stories: Phase III trial of sirukumab, Lyrica fails trial

November's top stories: Phase III trial of sirukumab, Lyrica fails trial

Pharma Technology Focus – Issue 42

Pharma Technology Focus – Issue 42

Pharma Technology Focus - Issue 41

Pharma Technology Focus - Issue 41

October's top stories: New cancer drug delivery approach, J&J Ebola trial

October's top stories: New cancer drug delivery approach, J&J Ebola trial

Pharma Technology Focus - Issue 40

Pharma Technology Focus - Issue 40

September's top stories: GSK-Theravance COPD study, AstraZeneca cUTI results

September's top stories: GSK-Theravance COPD study, AstraZeneca cUTI results